Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
about
Ultrasensitive detection of DNA and protein markers in cancer cellsEpstein-barr virus sequence variation-biology and diseaseThe Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disordersAscorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.Target DNA detection and quantitation on a single cell with single base resolution.CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.The expression and function of Epstein-Barr virus encoded latent genesEpstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?Humanized mouse models of epstein-barr virus infection and associated diseases.EBV and HIV-Related LymphomaBurkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Mice with human immune system components as in vivo models for infections with human pathogens.Skipping the two-step? Possible mechanisms of Epstein-Barr virus reactivation.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention.Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative diseaseImmunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection.Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hostsImproved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease modelPresence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.An in vivo model of human multidrug-resistant multiple myeloma in SCID miceCharacterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency.Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latencyHigh expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderPlasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes
P2860
Q26781035-0CF0832D-83E8-4B23-B896-31FF650C4E58Q27003183-FF878CDE-C82E-45BE-8778-40618C0C6F9BQ30278553-43CE4098-6442-488F-86FC-F44530AFC724Q33263443-064BB034-C36A-44A3-B22F-DEF79FFE3B83Q33650689-EE50AE73-26DC-4407-9E6A-FF5A3C028CADQ33748089-CC7251F4-D354-4E9A-8C89-AF84EA6C7CDEQ33816120-87350360-E6D1-4114-AD47-C99494D28839Q33851257-5DAC6F7E-E787-4806-958C-AFC52FC4034AQ33998709-1C9EE2CF-CE1A-4955-BE3C-C81858B372A0Q34089485-4FAC977C-9AB2-4360-ACBF-96A7027C08E5Q34123922-578D2397-EC79-4CF9-A76D-4B33775330ADQ34123985-FFEBBCF4-89E5-4067-A954-0BCA810EE457Q34302121-973B13AF-8DCC-42AF-AC9C-21302E795911Q34372087-A6889746-5EAC-49CA-9C9B-949719DF90BCQ34533579-3B0E2588-6951-40F8-B58E-F2806E22EEF8Q34549450-E1D65272-A384-46CB-9399-5F24D14AA548Q34658852-C4BCDD9A-1C5D-443A-B93D-FA25B18D7672Q34920166-6332040A-9FF8-4CBB-BBBE-A09709B8175FQ35186877-9BB4C96C-2FAD-4FA9-91FB-F872D64BADC3Q35242466-1FDF57B7-6CA8-4F9B-BAEE-A5777966BF71Q35276631-AB5B91EA-B0C7-40FC-81B4-72CEC220DB3FQ35494359-847508E9-9E74-4E4A-A0E0-3F095383DDBDQ35550073-0B351623-C85A-4406-94E1-58F9E3D01598Q35747109-74815222-A41F-4153-8FF2-2B4EA9EFDE04Q35765016-F0D4E32A-199B-4641-ADDF-F411C91C14E5Q35765267-911FFA1D-65DC-4BED-B6F4-F6C986D0B213Q35795065-1339B352-79C2-4608-88B0-5ED1D84FA853Q35815850-0ABDE3EF-F58A-41DB-A04C-4479D9E6C78CQ35822004-3CA75CFE-0E5C-4528-A4A0-BF34CA0962F8Q35831685-CEC0741B-5C0F-428E-AE60-5F0F6AFDE2CDQ35831688-B899B73E-CBDC-40E6-A5E1-94CC9218E079Q35832063-7F372CD6-BB4C-4891-9E0A-A3CD699F92CCQ35832279-F1791DE2-71F6-492D-A353-F29B2FA9B392Q35832500-D7FA0573-B3E0-4A6F-9C8E-131E8765A859Q35832561-45A39C08-4504-44E6-A674-1CD2EFB54A51Q35833217-34E01FBA-CA22-421B-8507-A3EB6182D23FQ35833524-7B8E676B-65E5-425D-A2E4-5BD3B2725A7AQ35833821-EBE23115-8C82-4AB6-B524-9788072F7A93Q36041314-D963AD0E-2F92-42A8-811A-EB19437CD751Q36048272-95715853-04B8-4E27-BB41-6E994E21E62E
P2860
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Epstein-Barr virus (EBV)-assoc ...... EBV-positive lymphomas in man
@en
type
label
Epstein-Barr virus (EBV)-assoc ...... EBV-positive lymphomas in man
@en
prefLabel
Epstein-Barr virus (EBV)-assoc ...... EBV-positive lymphomas in man
@en
P2093
P2860
P356
P1476
Epstein-Barr virus (EBV)-assoc ...... EBV-positive lymphomas in man
@en
P2093
A B Rickinson
S Henderson
P2860
P304
P356
10.1084/JEM.173.1.147
P407
P50
P577
1991-01-01T00:00:00Z